U.S. markets closed
  • S&P 500

    4,411.79
    +44.31 (+1.01%)
     
  • Dow 30

    35,061.55
    +238.20 (+0.68%)
     
  • Nasdaq

    14,836.99
    +152.39 (+1.04%)
     
  • Russell 2000

    2,209.65
    +10.17 (+0.46%)
     
  • Crude Oil

    72.17
    +0.26 (+0.36%)
     
  • Gold

    1,802.10
    -3.30 (-0.18%)
     
  • Silver

    25.24
    -0.14 (-0.56%)
     
  • EUR/USD

    1.1770
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.2860
    +0.0210 (+1.66%)
     
  • GBP/USD

    1.3754
    -0.0013 (-0.10%)
     
  • USD/JPY

    110.5100
    +0.3950 (+0.36%)
     
  • BTC-USD

    34,091.62
    +634.12 (+1.90%)
     
  • CMC Crypto 200

    786.33
    -7.40 (-0.93%)
     
  • FTSE 100

    7,027.58
    +59.28 (+0.85%)
     
  • Nikkei 225

    27,548.00
    +159.80 (+0.58%)
     

Sanofi, Walvax COVID-19 Vaccine Phase 3 Trials to Commence in Mexico: Reuters

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Mexico Foreign Minister Marcel Ebrard said that the country would begin phase 3 trials for COVID-19 vaccines by Sanofi SA (NASDAQ: SNY) and China's Walvax soon.

  • Mexico's health regulator Cofepris approved trials of the Sanofi vaccine, which uses a recombinant protein-based technology, Ebrard added, reports Reuters.

  • "In Mexico, phase 3 of very diverse vaccines have already been carried out or are being carried out," Ebrard said in a virtual event. "Two new phase 3 (trials) are about to start... one is Walvax, which is a Chinese vaccine.. and today they notified us via Cofepris, (the other is) Sanofi, with a recombinant protein."

  • Mexico's own "Patria" COVID-19 vaccine will enter phase two trials shortly, Ebrard said. Emergency use approval for the home-grown vaccine is expected in 2021.

  • Mexico has so far received about 33.5 million vaccine doses from foreign suppliers, including Pfizer Inc (NYSE: PFE), AstraZeneca Plc (NASDAQ: AZN), and China's Sinovac Biotech Ltd (NASDAQ: SVA), according to government data.

  • Ebrard said Mexico would have 40 million doses by June, increasing to 65 million by July.

  • Price Action: SNY shares are up 0.71% at $54.05 during the premarket session on the last check Tuesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.